Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
25.3% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Neuren Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
US And EU Regulation Will Erode Prospects Yet Offer Hope
Key Takeaways Heavy reliance on DAYBUE and single-indication focus exposes Neuren to significant revenue concentration and regulatory risk. Growing competition, regulatory pressures, and reimbursement scrutiny threaten future margins and the company's long-term growth potential.
View narrative
AU$18.60
FV
4.3% undervalued
intrinsic discount
-24.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Iluka Resources
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Rising Costs And Depleting Reserves Will Erode Long-Term Profitability
Key Takeaways Increased regulatory costs and resource depletion are expected to erode margins and weigh on long-term profitability and cash flow. Structural changes in material demand and concentrated customer exposure heighten risks to revenue growth and project returns.
View narrative
AU$5.30
FV
20.0% overvalued
intrinsic discount
10.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Geron
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Drug Pricing Controls And Approval Delays Will Curb Viability
Key Takeaways Overdependence on a single product and rising competition threaten revenue stability and long-term market share. Stricter global pricing, regulatory pressures, and challenging funding conditions may constrain growth, margins, and future innovation.
View narrative
US$1.00
FV
42.0% overvalued
intrinsic discount
37.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Root
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Privacy Concerns And Competition Will Harm Pricing Yet Enable Recovery
Key Takeaways Heavy dependence on data-driven, AI-powered models and digital adoption creates growth potential, but also exposes Root to regulatory risks and competitive pressures that threaten differentiation. Limited scale and exposure to external volatility make earnings unpredictable, while unproven models and rising claims costs could undermine profitability despite technological investments.
View narrative
US$105.00
FV
16.2% undervalued
intrinsic discount
8.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Life360
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Privacy Regulations And Rival Platforms Will Erode Value
Key Takeaways Growing privacy regulations and consumer concerns threaten Life360's ability to monetize data, jeopardizing ad revenue, subscription growth, and profitability. Competition from major device makers and rising regulatory risks erode differentiation, driving down margins and weakening Life360's long-term user engagement.
View narrative
AU$27.32
FV
69.6% overvalued
intrinsic discount
17.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
V.F
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Vans, North Face, And Timberland Will Face Declining Demand
Key Takeaways Structural decline in legacy brands and chronic demand weakness are driving sustained revenue and profit challenges, with turnaround efforts unlikely to fully offset these pressures. Rising environmental, regulatory, and reputational costs, combined with increased discounting, are compressing margins and undermining long-term earnings power.
View narrative
US$10.00
FV
36.7% overvalued
intrinsic discount
-1.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Five9
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
AI Risks And Data Laws Will Limit Yet Spur Recovery
Key Takeaways Advancing AI technology and evolving customer needs may outpace Five9's capabilities, risking market share loss and pressured long-term earnings. Expanding internationally and innovating boosts margins now, but rising compliance demands and sales cycle delays may hinder future revenue growth and add operational risk.
View narrative
US$28.00
FV
4.6% undervalued
intrinsic discount
7.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Alkami Technology
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Consolidation And Competition Will Restrict Markets Though Digital Tailwinds Persist
Key Takeaways Heavy reliance on regional and community banks exposes Alkami to risks from sector consolidation and heightened customer concentration, potentially limiting revenue stability and growth. Intensifying competition, escalating compliance costs, and sustained R&D investment could compress margins, especially if digital adoption or top-line growth slows.
View narrative
US$29.00
FV
14.2% undervalued
intrinsic discount
24.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
SolarEdge Technologies
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Fading Tax Credits And Chinese Rivalry Will Deter Prospects
Key Takeaways Heavy dependence on U.S. subsidies and regulatory support creates significant risk if government incentives are cut or policies shift unexpectedly. Intensifying global competition, supply chain disruptions, and volatile currency exposure threaten profit margins and long-term earnings stability.
View narrative
US$8.24
FV
288.4% overvalued
intrinsic discount
9.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies